Quest Diagnostics Long-Term Investments 2010-2024 | DGX

Quest Diagnostics long-term investments for the quarter ending September 30, 2024 were $0.125B, a 3.85% decline year-over-year.

  • Quest Diagnostics long-term investments for 2023 were $0.135B, a 2.27% increase from 2022.
  • Quest Diagnostics long-term investments for 2022 were $0.132B, a 6.38% decline from 2021.
  • Quest Diagnostics long-term investments for 2021 were $0.141B, a 72.94% decline from 2020.

Quest Diagnostics Long-Term Investments 2010-2024 | DGX

  • Quest Diagnostics long-term investments for 2023 were $0.135B, a 2.27% increase from 2022.
  • Quest Diagnostics long-term investments for 2022 were $0.132B, a 6.38% decline from 2021.
  • Quest Diagnostics long-term investments for 2021 were $0.141B, a 72.94% decline from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$19.5B
DaVita (DVA)$13.6B
Encompass Health (EHC)$10.2B
Chemed (CHE)$8.6B
Elanco Animal Health (ELAN)$6.6B
RadNet (RDNT)$6.1B
Option Care Health (OPCH)$3.9B
Amedisys (AMED)$3B
LifeStance Health (LFST)$2.8B
Astrana Health (ASTH)$2.4B
Addus HomeCare (ADUS)$2.3B
U.S Physical Therapy (USPH)$1.5B
Aveanna Healthcare Holdings (AVAH)$1.1B
Pennant (PNTG)$1.1B
Atai Life Sciences (ATAI)$270M
Daxor (DXR)$45M
Psychemedics (PMD)$14M
MEDIROM Healthcare Technologies (MRM)$14M
ATI Physical Therapy (ATIP)$8M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M